Clinical Value of Serum Thrombospondin-2 Combined with CA19-9 in Early Diagnosis of Gastric Cancer

Figure 4

The detected performance of THBS2 and CA19-9 for early gastric cancer. (a) Diagnostic performance of THBST in addition to CA19-9 to differentiate early gastric cancer patients from a healthy control. (b) Diagnostic performance of THBST in addition to CA19-9 to differentiate early gastric cancer patients from benign gastric tumor patients.

(a)

(b)